Studies from Harvard T.H. Chan School of Public Health Yield New Information about Biologics (Role of Allergen Immunotherapy and Biologics In Allergic Diseases).
| Zdroj: | Vaccine Weekly; 12/2/2024, p3673-3673, 1p |
|---|---|
| Abstrakt: | A recent study from the Harvard T.H. Chan School of Public Health explores the roles of allergen immunotherapy (AIT) and biologics in treating allergic diseases. The research highlights the mechanisms of AIT and biologics in modulating immune responses and discusses new strategies such as recombinant allergen-based vaccines. The study emphasizes the need for further research to develop personalized treatment strategies for allergic diseases. [Extracted from the article] |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|